
New treatment offers benefit for hypoxic laryngeal tumors
(HealthDay) -- For patients with squamous cell laryngeal cancer, regional control rates are improved with accelerated radiotherapy (AR) plus carbogen inhalation and nicotinamide (ARCON) treatment compared with AR-alone, with ...
Apr 18, 2012
0
0